Accelerating innovation

Projects

Cohort 5 (August 2025 - April 2027)

HEARTVEST: Novel Intracardiac Energy Harvester for Self-Powering Leadless Pacemakers

New generation of parenteral nutrition for infected preterm infants

Advancement of a novel ADC for hard-to-treat cancers

ChipNMR -visualize cell metabolism

Commercializing cell-derived heparins for improved anticoagulant medicines

Targeted complement inhibitors as novel therapeutic for diabetic nephropathy

Development of monoclonal antibody for migraine treatment

100% liquid-to-liquid fermentation for sustainable bulk chemicals

Translating Neuroscience into Next-Generation Treatments

Cohort 4 (August 2024 - July 2026)

Novel cell-based therapy for progressive multiple sclerosis

CarboCell Antibiotics - Precision Delivery: Transforming Surgical Outcomes, Reducing Costs, Saving Lives

Developing alligamycin to fight off invasive fungal infections

Developing non-covalent Keap1-Nrf2 inhibitors as drug candidates for chronic kidney disease

Polymer platform technology enhancing oral delivery of biopharmaceutical molecules

Y-king Biologics - A universal platform for enhancing tomorrow's biologics

Cohort 3 (January 2024 - December 2025)

Developing Peptide Therapeutics for diseases caused by Nonsense Mutations: from Hit to Lead

Development of glycan-based cancer vaccines

AorticPhlex – a supportive annuloplasty ring for patients with leaking heart valves

Unlocking the diagnostic value of urinary acid/base biomarkers

GALA LFD: Farmsite preventive care of calf disease – For better welfare, farm life, and economy

Stress testing of adaptive soft foam for undisturbed wound healing

Cohort 2 (August 2023 - July 2025)

Using a newly discovered hormone for the treatment of preeclampsia

Alumni

Cohort 2 (August 2023 - July 2025)

Scaling-up nitrogen biosensors to enhance sustainable legume crop production

Diagnostic Biomarkers for Pancreatic Cancer - Development of a blood-based diagnostic test for early detection of pancreatic cancer

Developing novel treatment for management of menopausal symptoms and complications

Treatment of haploinsufficiency disorders through targeted upregulation of protein expression using artificial small RNA

Cohort 1 (January 2023 - December 2024)

Developing New Therapy for Chronic Kidney Disease (CKD)

Lead optimization and pre-clinical testing of a NASH therapeutic with a novel mode of action

Non-opioid pain relief through a novel target

Smart MultiSensor for Industrial Biotechnology (BiotechSens)

Preventing chemotherapy-induced peripheral neuropathy